Karolinska Development portfolio company BioArctic enters into Collaboration with AbbVie for Parkinson's Disease Research
STOCKHOLM, Sept. 20, 2016 (GLOBE NEWSWIRE) -- Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company BioArctic AB has entered into a strategically important collaboration with AbbVie (NYSE: ABBV), a global biopharmaceutical …